Suppression of beta2 microglobulin by pentoxiphylline therapy in asymptomatic HIV infected individuals

Indian Journal of Medical Research

Volumn 113, Issue MAR., 2001, Pages 75-77

  Wanchu, A ^a   Arora, S ^a   Bhatnagar, A ^a   Sud, A ^a   Bambery, P ^a   Singh, S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Beta2 microglobulin; Enzyme immunoassay; HIV infection; Immune activation; Pentoxiphyllinet tumor necrosis factor

Indexed keywords

BETA 2 MICROGLOBULIN; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DRUG INHIBITION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; MALE; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

ADULT; BETA 2-MICROGLOBULIN; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PENTOXIFYLLINE;

EID: 0034909275     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Role of apoptosis in HIV disease pathogenesis
2. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
3. Strategies to restrain this proinflammatory cytokine
4. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxiphylline
5. Dexamethasone and pentoxiphylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway
6. Pentoxiphylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-α) production in lepromatous, leprosy patients with erythema nodosum leprosum (ENL)
7. Neurologic manifestations of HIV infection
8. High-dose pentoxiphylline in patients with AIDS: Inhibition of tumor necrosis factor production
9. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: Quality control procedures
10. Serum HIV- 1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV- 1 infected individuals
11. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection
12. β2-microglobulin and immunoglobulins are more useful markers of disease progression in HIV than neopterin and adenosine deaminase
13. Inhibition of cytotoxicity and cytokine release of CD8+ HIV-specific cytotoxic T lymphocytes by pentoxiphylline
14. Pentoxiphylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viraemia in asymptomatic HIV-seropositive persons
15. Pentoxiphylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor k B activation
16. HIV wasting syndrome: Treatment update
17. Pentoxiphylline reduces nitric oxide production among patients with HIV infection
18. The predictive value of several markers in the progression to acquired immunodeficiency syndrome